The largest time-matched mean QTcF difference compared with placebo for the therapeutic dose of NOMAC/E2 was 1.6 ms , with an upper limit ( UL ) of a one-sided 95 % confidence interval ( CI ) of 5.2 ms , and 3.1 ms with an UL 95 % CI of 7.0 ms for the supratherapeutic dose .